Pheton Holdings Ltd Class A Ordinary Shares (PTHL) Competitors $4.25 -0.07 (-1.62%) (As of 09/19/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsTrends PTHL vs. MDT, MASI, TMDX, ITGR, LIVN, CNMD, SLNO, INMD, BLFS, and ZYXIShould you be buying Pheton Holdings Ltd Class A Ordinary Shares stock or one of its competitors? The main competitors of Pheton Holdings Ltd Class A Ordinary Shares include Medtronic (MDT), Masimo (MASI), TransMedics Group (TMDX), Integer (ITGR), LivaNova (LIVN), CONMED (CNMD), Soleno Therapeutics (SLNO), InMode (INMD), BioLife Solutions (BLFS), and Zynex (ZYXI). These companies are all part of the "electromedical equipment" industry. Pheton Holdings Ltd Class A Ordinary Shares vs. Medtronic Masimo TransMedics Group Integer LivaNova CONMED Soleno Therapeutics InMode BioLife Solutions Zynex Pheton Holdings Ltd Class A Ordinary Shares (NASDAQ:PTHL) and Medtronic (NYSE:MDT) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, community ranking, institutional ownership, analyst recommendations, risk, media sentiment, dividends, earnings and valuation. Do analysts recommend PTHL or MDT? Medtronic has a consensus target price of $92.92, suggesting a potential upside of 3.64%. Given Medtronic's higher probable upside, analysts clearly believe Medtronic is more favorable than Pheton Holdings Ltd Class A Ordinary Shares.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Pheton Holdings Ltd Class A Ordinary Shares 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/AMedtronic 1 Sell rating(s) 9 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 2.33 Which has higher valuation and earnings, PTHL or MDT? Medtronic has higher revenue and earnings than Pheton Holdings Ltd Class A Ordinary Shares. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPheton Holdings Ltd Class A Ordinary Shares$628.59KN/AN/AN/AN/AMedtronic$32.58B3.53$3.68B$2.7532.59 Does the media favor PTHL or MDT? In the previous week, Medtronic had 18 more articles in the media than Pheton Holdings Ltd Class A Ordinary Shares. MarketBeat recorded 18 mentions for Medtronic and 0 mentions for Pheton Holdings Ltd Class A Ordinary Shares. Medtronic's average media sentiment score of 0.85 beat Pheton Holdings Ltd Class A Ordinary Shares' score of 0.00 indicating that Medtronic is being referred to more favorably in the news media. Company Overall Sentiment Pheton Holdings Ltd Class A Ordinary Shares Neutral Medtronic Positive Is PTHL or MDT more profitable? Medtronic has a net margin of 12.06% compared to Pheton Holdings Ltd Class A Ordinary Shares' net margin of 0.00%. Medtronic's return on equity of 13.68% beat Pheton Holdings Ltd Class A Ordinary Shares' return on equity.Company Net Margins Return on Equity Return on Assets Pheton Holdings Ltd Class A Ordinary SharesN/A N/A N/A Medtronic 12.06%13.68%7.67% Does the MarketBeat Community favor PTHL or MDT? Medtronic received 1582 more outperform votes than Pheton Holdings Ltd Class A Ordinary Shares when rated by MarketBeat users. CompanyUnderperformOutperformPheton Holdings Ltd Class A Ordinary SharesN/AN/AMedtronicOutperform Votes158275.88% Underperform Votes50324.12% Do insiders and institutionals hold more shares of PTHL or MDT? 82.1% of Medtronic shares are owned by institutional investors. 0.3% of Medtronic shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. SummaryMedtronic beats Pheton Holdings Ltd Class A Ordinary Shares on 12 of the 12 factors compared between the two stocks. Ad Paradigm PressMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.Click here to see it because it’s a SHOCKER… Get Pheton Holdings Ltd Class A Ordinary Shares News Delivered to You Automatically Sign up to receive the latest news and ratings for PTHL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PTHL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat are MarkeBeat Followers?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PTHL vs. The Competition Export to ExcelMetricPheton Holdings Ltd Class A Ordinary SharesElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$3.51B$5.69B$8.49BDividend YieldN/A1.52%4.97%4.07%P/E RatioN/A9.64146.0718.63Price / SalesN/A43.951,658.6572.48Price / CashN/A74.0737.2331.48Price / BookN/A3.994.924.58Net IncomeN/A$94.61M$115.07M$225.02M7 Day Performance8.51%2.65%6.40%5.60%1 Month PerformanceN/A0.69%7.26%6.00%1 Year PerformanceN/A13.56%31.65%14.08% Pheton Holdings Ltd Class A Ordinary Shares Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MDTMedtronic4.5734 of 5 stars4.57 / 5 stars$89.61+1.7%$92.92+3.7%+6.5%$114.90B$32.58B32.5995,000MASIMasimo4.6481 of 5 stars4.65 / 5 stars$112.28-1.8%$144.67+28.8%+14.5%$5.97B$2.02B76.385,200News CoverageTMDXTransMedics Group2.9075 of 5 stars2.91 / 5 stars$163.80+5.0%$171.44+4.7%+164.7%$5.40B$358.76M-481.76210Insider SellingGap UpITGRInteger1.8061 of 5 stars1.81 / 5 stars$131.19+2.2%$133.86+2.0%+58.1%$4.40B$1.67B45.3910,500News CoveragePositive NewsGap UpLIVNLivaNova3.9423 of 5 stars3.94 / 5 stars$51.69+1.2%$70.80+37.0%-11.4%$2.80B$1.21B-86.152,900Analyst UpgradeNews CoveragePositive NewsCNMDCONMED4.0355 of 5 stars4.04 / 5 stars$75.82-0.2%$79.80+5.2%-29.6%$2.34B$1.28B29.054,000Ex-DividendSLNOSoleno Therapeutics4.4914 of 5 stars4.49 / 5 stars$53.42-0.2%$67.14+25.7%+1,029.7%$1.78BN/A-19.9330Positive NewsGap UpINMDInMode3.824 of 5 stars3.82 / 5 stars$17.70+1.4%$22.40+26.6%-48.5%$1.49B$416.63M8.39480Gap UpBLFSBioLife Solutions0.9277 of 5 stars0.93 / 5 stars$25.50+7.5%$26.20+2.7%+86.3%$1.17B$139.96M-17.96440Short Interest ↓News CoveragePositive NewsZYXIZynex3.9007 of 5 stars3.90 / 5 stars$8.45+3.3%$14.00+65.7%+1.7%$268.20M$184.32M36.741,100Positive News Related Companies and Tools Related Companies: Medtronic Alternatives Masimo Alternatives TransMedics Group Alternatives Integer Alternatives LivaNova Alternatives CONMED Alternatives Soleno Therapeutics Alternatives InMode Alternatives BioLife Solutions Alternatives Zynex Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:PTHL) was last updated on 9/19/2024 by MarketBeat.com Staff From Our PartnersElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredThis diversified cannabis pioneer could make huge moves soonThe cannabis industry seems deeply saturated, so how do you know where to best invest your money? Let’s start ...Greenlane | SponsoredWar on Elon Escalates… Elon Musk, the guy slated to become the world’s first trillionaire by 2027, has publicly called for the adopti...Porter & Company | SponsoredUnlock the Secret to Easy Wins with Iron CondorsDiscover the power of Iron Condor trades – a low-risk, high-reward strategy that allows you to profit consiste...Netpicks | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredForget ChatGPT: Follow the AI Retirement PlaybookEveryone’s talking about AI right now, but I’ve been talking about it for years. Follow this two-part playb...Brownstone Research | SponsoredDump Nvidia, Apple, and Tesla Before It’s Too LateThe financial world is on high alert. Billionaires like Warren Buffett, Jeff Bezos, and Elon Musk are dumpi...InvestorPlace | SponsoredNew September Stock WarningSeptember is the most volatile month of the year for stocks. And after the brutal tech selloff, one Wall St...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pheton Holdings Ltd Class A Ordinary Shares Please log in to your account or sign up in order to add this asset to your watchlist. Share Pheton Holdings Ltd Class A Ordinary Shares With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
